Collectively, these findings suggest that hWJMSC-derived exosomes may mitigate HFD-induced metabolic dysfunction by reinforcing SIRT1-mediated metabolic processes, which consequently contributes to the protection against hepatic steatosis and insulin resistance. The gene discussed is SIRT1; the disease is Insulin resistance.